Faced with the encroaching threats of patent expirations and generics, biopharma companies in 2024 invested 33% more in ...

Cambridge-based biopharmaceutical company Sage Therapeutics filed a lawsuit against their partner, the biotechnology company ...

Ventyx Biosciences Inc. (VTYX) stock has reached a 52-week low, trading at $1.57, marking a significant downturn for the biopharmaceutical company. With a market capitalization of $114.5 million, the ...

Needham & Company LLC reiterated their hold rating on shares of Sage Therapeutics (NASDAQ:SAGE – Free Report) in a research report report published on Wednesday,Benzinga reports. Other equities ...

Needham & Company LLC restated their hold rating on shares of Gilead Sciences (NASDAQ:GILD – Free Report) in a research report sent to investors on Wednesday,Benzinga reports. Other analysts also ...

We recently published a list of 10 Best Nasdaq Stocks Under $5 to Buy. In this article, we are going to take a look at where Arbutus Biopharma Corp. (NASDAQ:ABUS) stands against other best Nasdaq ...

Quantum BioPharma Ltd (NASDAQ:QNTM) shares are rising Tuesday after the company announced positive clinical trial results for ...

MIRAMAR, Fla., Feb. 03, 2025 (GLOBE NEWSWIRE) -- HCW Biologics Inc. (“HCWB” or the “Company”) (NASDAQ: HCWB), a U.S.-based clinical-stage biopharmaceutical company focused on discovering and ...

To manage these variations correctly, biopharmaceutical companies must obtain sufficient regulatory information. This entails the continuous tracking of regulatory changes, understanding of ...

A recent report from Stifel showed that 30% of licensing deals from big pharma companies now involve a Chinese biotech.